Patent · US Active

Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase

US7622492B2 · kind B2 · utility

0Cited by

1References

22Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Bruce Lester Banner · Wayne, US
Joseph Anthony Bilotta · New York, US
Nader Fotouhi · Berkeley Heights, US
Paul Gillespie · Westfield, US
Robert Alan Goodnow, Jr. · Gillette, US
Matthew Hamilton · Hackettstown, US
Nancy-Ellen Haynes · Cranford, US
Agnieszka Kowalczyk · Mine Hill, US
Alexander V. Mayweg · Basel, CH
Michael Paul Myers · Ramsey, US
Sherrie Lynn Pietranico-Cole · Nutley, US
Nathan Robert Scott · Livingston, US
Kshitij Chhabilbhai Thakkar · Clifton, US
Jefferson Wright Tilley · North Caldwell, US
Kevin Richard Guertin · Verona, US

Key dates

Filing date	Aug 18, 2006
Grant date	Nov 24, 2009
Priority date	—
Expiry date	Dec 22, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are compounds of the formula (I):as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.